Epilia: Epilepsy Commun Search

CLOSE


Instructions to authors

  • HOME
  • AUTHOR INFORMATION
  • Instructions to authors

The author’s guideline for ‘Epilia: Epilepsy and Community’, the official journal of Korean Clinical Epilepsy Research Society

General Information

1. Authorship

All authors should have contributed significantly, and take responsibility in the manuscript. The editorial board may question each author’s contributions to the paper.

2. Publication ethical policy

Authors should specify within the manuscript whether ethical standards were used in their research. The policies on the research and publication ethics for the ‘Epilia: Epilepsy and Community’ comply with ‘Good Publication Practice Guidelines for Medical Journals (http://kamje.or.kr/publishing_ethics.html)’. Research involving human subjects must comply with the principles of the Declaration of Helsinki (1964). All manuscript involving experimental investigation in human or animal subjects, should describe the approval by an institutional review board (IRB) on human or animal research, and the appropriate informed consent procedures for human subjects.

3. Conflict of interest

Authors should disclose any financial support or potential conflicts of interests that possibly influence the research or interpretation of data.

4. Copyright transfer

The copyright of published manuscripts is held by Korean Clinical Epilepsy Research Society. Any published data, tables, or figures cannot be reproduced elsewhere without permission from the copyright holder.

All authors must agree and sign the authors ‘consent form’ regarding Copyright Transfer Agreement, Conflict of Interest, and Ethical Statement, which can be downloaded from the journal homepage (http://jepilia.org/authors/copyright_transfer_agreement.php).

Manuscript Preparation

Authors should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (Ann Intern Med 1997;126:36-47). Manuscript can be written in Korean or English language.

The main text of the manuscript and all tables included in the submission must be provided as Microsoft Word files (.doc or .docx). Margins of 2.5 cm are required on each side. The text must be written in double-spaced, 12-point (English) or 10-point (Korean) font.

1. General style

Epilia: Epilepsy and Community publishes Original Article, Review or Special report, Case report, and Letter to the Editor.

1) Original article

The Original article present original research findings in the fields of seizure and epilepsy. The Original article should include;

  • (1) Title page: Title, full names of all authors and their affiliations, and corresponding author’s affiliation should be included.
  • (2) Main body (Do not include author information): It should be prepared in the order of Title, Abstract, Introduction, Methods, Results, Discussion, Acknowledgment, Conflict of Interest, Author Contributions, and References.
  • (3) Table and Figure: Table with title and legend, and Figure with title and legend. Tables and Figures must be numbered consecutively in the order in which they are cited in the manuscript. (Abstracts should not exceed 250 words, and references should not exceed 45 references. Keywords are limited to six or under.)

2) Review or Special report

The Review or Special report presents review of on a specific topic on seizure and epilepsy. The editorial board can select or request topic or author for publication. Review or Special report should include: Title page, Main body (Title, Abstract, Introduction, Main text, Conclusion, Acknowledgment, Conflict of Interest, Author Contributions, and References), and Table and Figures (Abstracts should not exceed 250 words, and references should not exceed 60 references. Keywords are limited to six or under).

3) Case report

Interesting case with unusual presentation, diagnose, treatment or first reported case can be presented. The report elaborate on the focus and should not be redundant. Case report should include: Title page, Main body (Title, Abstract, Introduction, Case, Conclusion, Acknowledgment, Conflict of Interest, Author Contributions, and References), and Table and Figure (Abstracts should not exceed 150 words, and references should not exceed 10 references. Keywords are limited to three or under. The total number of figures and/or tables is limited to 3).

4) Letter to the editor

Letter to the Editor is for opinion and constructive criticism on recent publications of Epilia: Epilepsy and Community within a year. Editorial board will review the manuscript for publication. Letter to the Editors should include: Title page, Main body (Title, Main text, Acknowledgment, Conflict of Interest, Author Contributions, and References), and Table and Figure (An abstract is not required. Main text should not exceed 750 words. References are limited to 5 references. The total number of figures and/or tables is limited to 1).

2. Manuscript

1) Title page

The Title page should contain the title, and authors’ information. The full names of all authors and their affiliations should be written in consecutive order using lower case superscript numbers. Corresponding authors’ address should include, name, affiliation, address, phone number, fax number, and E-mail address.

2) Main body

Author information should not be included in the main body.

(1) Abstract
The abstract needs to be written in English. The abstract of Original Articles should be structured under Objective, Methods, Results, and Discussion. For Review, Special report, and Case Report, the abstract should be organized in one unstructured paragraph. The abstract for letter to the editor is not necessary. The abstract for Special report can be skipped according to the content of the manuscript.
Keywords are listed under abstract, and it can be selected from the Medical Subject Heading (MeSH) of Index Medicus.

(2) Introduction
State the purpose of the study with relevant background descriptions.

(3) Methods
Describe in sufficient details including plan, subjects and methods, so that the work can be duplicated. Describe logically how the patient’s diagnosis was confirmed and how the data were analyzed. For instruments and pharmaceuticals, state the manufacturer, city and nationality in parentheses. All studies should describe the approval by an institutional review board on human or animal research, and the appropriate informed consent procedures for human subjects.

(4) Results
Describe results of the study clearly and in logical order. In the case of experiments involving biological measurement with large variation, the statistical analysis is required. The detailed description of results shown in tables is not required, but important points can be briefly described.

(5) Discussion
Concisely interpret the results and relate them to previous studies. Clearly describe the results related to the purpose of the research. Do not rewrite the results, but emphasize the significant and important research findings. Discuss the significance and the limitation of the study.

(6) Acknowledgment
List the person who have made substantial contributions to the research and/or manuscript (e.g., study conduct, data collection, data analyses, writing or editing assistance), but who do not fulfill authorship criteria. All persons listed in the Acknowledgments have provided the corresponding author with permission to be named in the manuscript. If there is nothing to disclose, declare 'None'.

(7) Conflict of Interest
Authors should disclose any financial or other interests that could be potentially perceived to inappropriately influence author’s judgement. If there is nothing to disclose, declare 'None'.

(8) Author Contributions
The contributions of all authors must be described. List the initials of the authors who have contributed to at least one of the key contributions. Examples of the authors’ contributions are as follows: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing—original draft, and Writing— review & editing.

(9) References
Reference format should conform with that specified in “Uniform Requirements for Manuscripts Submitted to Biomedical Journals-Vancouver style”.

  • - References should be written in English language.
  • - References should be numbered serially in the text using Arabic number as unparenthesized superscripts.
  • - When three or more references are cited at one place in the manuscript, a hyphen should be used to join the first and last numbers of a series; commas should be used without spaces to separate other parts of a multiple-reference citation. (e.g., 3-5 or 3-5,7).
  • - Provide all author’s names when fewer than six; when six or more, list the first three and add “et al.”
  • - For journal names, use abbreviations in italic type, as listed in the Index Medicus.
  • Personal communications, unpublished observations, and submitted manuscripts are not legitimate references for publication. They must be cited in the text only as (Kim SB, personal opinion) or (Kim SB, unpublished observation).
  • -“In press” citations must have been accepted for publication and the name of the journal or book publisher must be included.

Sample References
1. Journal article

  • Ex-1): Lee KS, Choi IS. A clinical study of brain tuberculomas based upon 20 case records. J Korean Neurol Assoc 1985;3:241-253.
  • Ex-2): Landrigan CP, Rothschild JM, Cronin JW, et al. Effect of reducing interns’ work hours on serious medical errors in intensive care units. N Engl J Med 2004;351:1838-1848.
  • Ex-3): Currie LJ, Harrison HB, Trugman JM, Bennett JP, Wooten GF. Early morning dystonia in Parkinson’s disease. Neurology 1998;51:283-285.
  • Ex-4): Shen HM, Zhang QF. Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ Health Perspect 1994;102 Suppl 1:275-282.

2. Book

  • Ex-1): Wyllie E. The treatment of epilepsy. 2nd ed. Baltimore: Williams & Wilkins, 1997;97-98.

3. Book chapter

  • Ex-1): Calne CB, Duvoision RFC, McGeer E. Speculation on the etiology of Parkinson’s disease. In: Hassler RG, Christ JF. Advances in neurology. 2nd ed. Vol. 40. New York: Raven Press, 1984;353-360.

4. Website

  • Ex-1): Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis [serial online] 1995 Jan-Mar [cited 1996 Jun 5]; 1(1): [24 screens]. URL:http://www.cdc.gov/ncidod/EID/eid.htm. Access date.

3) Table

Table must be submitted as separate files. English language is used for Table title and legend. Title should be written in phrase and the first letter of nouns and adjectives are capitalized. Legend should be written in sentences. Table must be self -contained and comprehensible without referring to the manuscript. Table should be numbered consecutively in the order in which they are cited in the manuscript. Table should appear as ‘Table’ and number after a space. Table should include at least 4 rows, and limited under one page. All abbreviations used in a table must be defined below the table (e.g., FT: frontotemporal, PO: parietooccipital). All symbols used in a table must be defined below the table (e.g., *, †, ‡, §, ∥, ¶, **, ††, ‡‡).

4) Figure

Figures must be submitted as separate files saved in JPEG, TIFF, or PPT format. English language is used for Figures title and legend. Title should be written in phrase and the first letter of nouns and adjectives are capitalized. Legend should be written in sentences. Figures must be self -contained and comprehensible without referring to the manuscript. Figures must be numbered consecutively in the order in which they are cited in the manuscript. Figures should appear as ‘Fig’ and number after a space. When more than two images for one figure, use Alphabet (e.g., Fig. 1A, Fig. 1B). All abbreviations used in a figure must be defined in the figure caption. (e.g., FT: frontotemporal, PO: parietooccipital). All symbols used in a figure must be defined for that figure (e.g., *, †, ‡, §, ∥, ¶, **, ††, ‡‡). Symbols may be defined in figure legend. The color print fee will be charged to the authors, when authors decide to color print the Figures.

Review Process

The Editor-in-Chief and Associate Editors first review if a submitted manuscript is suitable for review and publication. Editorial board can immediately reject in cases of 1) unrelated topic to the aims and scopes of Epilia: Epilepsy and Community, 2) have not followed author’s instructions, or 3) insufficient quality, novelty or importance to warrant publication. Manuscripts submitted are then sent to two different reviewers. Third reviewer can be selected for conflicting recommendations. Reviews are blinded to the author’s information.

Proofreading

After acceptance of all manuscripts, page proofs will be sent to the corresponding author for review and approval. Authors are responsible for conciseness, clarity, grammar, and spelling, but major editing is not allowed. Editorial board can make minor revision before the publication.

Submission

To submit a manuscript, please send submission files to epilia.journal@gmail.com.





ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Department of Neurology, Keimyung University Dongsan Medical Center
1035, Dalgubeol-daero, Dalseo-gu, Daegu 42601, Korea
Tel: +82-53-258-4376    Fax: +82-53-258-4380    E-mail: epilia.journal@gmail.com                

Copyright © 2022 by Korean Clinical Epilepsy Research Society.

Developed in M2PI

Close layer
prev next